Automated Summary
Key Facts
Rxeed, a third-party online marketplace for retail drugstores to buy and sell drugs, sued Caremark (which manages New Jersey's Medicaid prescription-benefits program) after alleging Caremark refused to accept Rxeed's drug-purchase histories for reimbursement and clawed back prior reimbursements. The court dismissed Rxeed's federal claim under 42 U.S.C. §1983, ruling that the Drug Supply Chain Security Act (DSCSA) does not confer enforceable rights to third-party platforms like Rxeed, as the statute focuses on dispensers and buyers rather than intermediaries.
Issues
The court considered whether the Drug Supply Chain Security Act (DSCSA) confers an enforceable private right of action under 42 U.S.C. §1983 on third-party platforms like RXEED. The court held that the DSCSA does not clearly establish such rights, as it focuses on dispensers and lacks rights-creating language for non-dispensers. Therefore, RXEED's §1983 claim was dismissed.
Holdings
- The court affirmed the dismissal with prejudice, concluding that amending the complaint would be futile as Rxeed has no enforceable right under the DSCSA. Additionally, Rxeed did not argue that the District Court should have exercised supplemental jurisdiction over the state-law claims.
- The court held that the Drug Supply Chain Security Act (DSCSA) does not confer enforceable rights to third-party platforms like Rxeed. The court found that the relevant provision of the DSCSA focuses on dispensers and buyers, not third-party platforms, and lacks rights-creating language or an unmistakable focus on entities like Rxeed. Therefore, Rxeed's §1983 claim fails because there is no violation of a federal right.
Remedies
The Third Circuit affirmed the District Court's dismissal of Rxeed's lawsuit against Caremark with prejudice, determining that Rxeed had no enforceable federal right under the Drug Supply Chain Security Act and that amending the complaint would be futile.
Legal Principles
The court applied the principle that to sue under 42 U.S.C. §1983, a plaintiff must demonstrate the statute creates enforceable rights. This requires both 'clearly and unambiguously use rights-creating terms' and an 'unmistakable focus on individuals like the plaintiff,' as established in Gonzaga Univ. v. Doe and Medina v. Planned Parenthood S. Atl.
Precedent Name
- Host Int'l, Inc. v. MarketPlace, PHL, LLC
- Medina v. Planned Parenthood S. Atl.
- Gonzaga Univ. v. Doe
Cited Statute
- Civil Rights Act of 1871
- Drug Supply Chain Security Act
Judge Name
- Bibas
- Porter
- Bove
Passage Text
- Section 360eee-1(d)(1)(A)(ii) has no language about third-party platforms, let alone rights-creating language or an unmistakable focus on entities like Rxeed. Because '[no]thing short of an unambiguously conferred right' is enough for a §1983 cause of action, Rxeed's claim fails.
- You cannot sue someone for violating your federal rights unless you have federal rights to violate. Rxeed sued Caremark for violating a law that it claims gave it rights. But because nothing in that law even hints at such rights, we will affirm the District Court's dismissal.
- To sue under §1983, a plaintiff must show a violation of his federal right, not just a federal law. Gonzaga v. Doe, 536 U.S. 273, 283 (2002). Not only must the underlying statute 'clearly and unambiguously use rights-creating terms,' but it 'must [also] display an unmistakable focus on individuals like the plaintiff.'